Login / Signup

Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study.

Figen EsenPerihan Ergin ÖzcanGünseli OrhunÖzlem Polatİlkay AnaklıGülçin Hilal AlayVerda Dinar TunaEmre ÇeliksoyMehmet KılıçMutlu MercanTufan Tukek
Published in: Current medical research and opinion (2021)
Clinically relevant benefits through adjunct IVIG treatment in COVID-19 need to be confirmed in a randomized, controlled trial.
Keyphrases
  • coronavirus disease
  • sars cov
  • early onset
  • low dose
  • replacement therapy
  • respiratory syndrome coronavirus